Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- FDA (2)
- And pursue injury compensation. When a vaccine is given as a countermeasure during a declared public health emergency (PHE) (1)
- And who have limited financial resources to obtain medical care (1)
- Commercial speech (1)
- Consumer products (1)
-
- E-cigarettes (1)
- ENDS (1)
- Federal law (1)
- Federalism (1)
- First Amendment (1)
- Food & Drug Law (1)
- GM food (1)
- GMOs (1)
- Genetically modified food (1)
- Innovative technologies (1)
- Keywords: tobacco (1)
- Lab grown meat (1)
- Marijuana (1)
- Nanotechnology (1)
- Post market surveillance (1)
- Product liability (1)
- Public health (1)
- Regulating in uncertainty (1)
- The problem is acute because of the limited availability of injury compensation. (1)
- This chapter argues that the potential for vaccine-related harms raises acute concerns for vulnerable populations. These harms have a disparate impact on low-income people (1)
- Vaping (1)
- Weather job losses (1)
- Who are disproportionately non-White (1)
Articles 1 - 4 of 4
Full-Text Articles in Food and Drug Law
Speech Regulation And Tobacco Harm Reduction, Jonathan Adler, Jacob James Rich
Speech Regulation And Tobacco Harm Reduction, Jonathan Adler, Jacob James Rich
Faculty Publications
Regulation of commercial speech is a major component of federal regulation of tobacco products. Since adoption of federal tobacco legislation, the Food and Drug Administration has asserted regulatory authority over ENDS and other vaping products as “tobacco products,” subjecting them to the same regulatory regime as traditional tobacco products even though such projects appear to pose less of a threat to public health. Such regulation, and the restriction on truthful speech in particular, may be having negative consequences for public health. Barring producers from informing consumers about the relative risks of vaping products and their potential to reduce smoking eliminates …
Vulnerable Populations And Vaccine Injury Compensation: The Need For Legal Reform, Katharine A. Van Tassel, Sharona Hoffman
Vulnerable Populations And Vaccine Injury Compensation: The Need For Legal Reform, Katharine A. Van Tassel, Sharona Hoffman
Faculty Publications
This chapter argues that the potential for vaccine-related harms raises acute concerns for vulnerable populations. These harms have a disparate impact on low-income people, who are disproportionately non-White, and who have limited financial resources to obtain medical care, weather job losses, and pursue injury compensation. When a vaccine is given as a countermeasure during a declared public health emergency (PHE), the problem is acute because of the limited availability of injury compensation.
Our Federalism On Drugs, Jonathan Adler
Our Federalism On Drugs, Jonathan Adler
Faculty Publications
Over the past decade, voters and legislatures have moved to legalize the possession of marijuana under state law. Some have limited these reforms to the medicinal use of marijuana, while others have not. Despite these reforms marijuana remains illegal under federal law. Although the Justice Department has not sought to preempt or displace state-level reforms, the federal prohibition casts a long shadow across state-level legalization efforts. This federal-state conflict presents multiple important and challenging policy questions that often get overlooked in policy debates over whether to legalize marijuana for medical or recreational purposes. Yet in a “compound republic” like the …
Regulating In Uncertainty: Animating The Public Health Product Safety Net To Capture Consumer Products Regulated By The Fda That Use Innovative Technologies, Including Nanotechnologies, Genetic Modification, Cloning, And Lab Grown Meat, Katharine A. Van Tassel
Faculty Publications
The past several decades have seen the creation of transformative new technologies that are being used to design innovative consumer product ingredients never seen before in nature. Examples include the use of nanotechnology and genetic modification, and, right around the corner, cloning and lab grown meat. These innovative technologies are harbingers of more pioneering consumer product ingredients to come. The remarkable pace of the development of ground-breaking new technologies means that the population is being steadily exposed to novel ingredients with unknown health risks.
Optimally, the Food & Drug Administration ("FDA") should be regulating these innovative, novel ingredients in consumer …